Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores - Summary - MDSpire
Advertisement
Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores
To explore the diagnostic value of extreme apical targeted biopsy (TBx) sampling for clinically significant prostate cancer (csPCa) detection in men with mid-apical prostate cancer-suspicious mpMRI lesions, specifically assessing its added value compared to mid-gland sampling.
Key Findings:
Median age of patients was 66 years with a median PSA of 7.7 ng/ml, indicating a typical demographic for prostate cancer screening.
TBx findings yielded 44% csPCa detection, with 57% of patients having a maximum PI-RADS score of 4, highlighting the effectiveness of targeted biopsies.
A median of 7 TBx cores were sampled per lesion, with varying detection rates between mid-gland and apical segments, suggesting the need for tailored biopsy approaches.
Interpretation:
The study suggests that extreme apical TBx may not significantly enhance csPCa detection rates compared to mid-gland sampling alone, indicating a need for optimized biopsy strategies that balance detection rates and patient safety.
Limitations:
The study did not account for the anatomical site of biopsies in previous series, which may limit the generalizability of the findings.
Potential morbidity associated with sampling from the apical region was not fully assessed, raising concerns about the safety of the procedure.
Conclusion:
Optimizing TBx strategies by potentially sparing extreme apical regions could reduce morbidity without compromising csPCa detection rates, thus improving patient outcomes.
by Sami-Ramzi Leyh-Bannurah, Svitlana Boiko, Dirk Beyersdorff, Fabian Falkenbach, Jonas Ekrutt, Tobias Maurer, Markus Graefen, Mykyta Kachanov, Lars Budäus
